Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| 1 |
Charles Schwab
SCHW
|
+$1.44B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.06B |
| 3 |
GE HealthCare
GEHC
|
+$519M |
| 4 |
Danaher
DHR
|
+$420M |
| 5 |
American Electric Power
AEP
|
+$387M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$941M |
| 2 |
Boeing
BA
|
+$880M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$819M |
| 4 |
Bank of America
BAC
|
+$705M |
| 5 |
Coca-Cola
KO
|
+$684M |
Sector Composition
| 1 | Healthcare | 16.71% |
| 2 | Technology | 14.92% |
| 3 | Financials | 12.44% |
| 4 | Consumer Discretionary | 11.46% |
| 5 | Industrials | 9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1976
SPDR Portfolio S&P 500 Growth ETF
SPYG
$41.7B
| $3.73M | ﹤0.01% |
46,415
+45,989
| +10,796% | +$3.7M |
|
1977
Usana Health Sciences
USNA
$557M
| $3.73M | ﹤0.01% |
138,295
+6,868
| +5% | +$185K |
|
1978
News Corp Class B
NWS
$18.2B
| $3.72M | ﹤0.01% |
122,641
-61,386
| -33% | -$1.86M |
|
1979
Accel Entertainment
ACEL
$938M
| $3.72M | ﹤0.01% |
375,365
-41,454
| -10% | -$411K |
|
1980
Columbia Financial
CLBK
$1.6B
| $3.72M | ﹤0.01% |
247,978
+177,851
| +254% | +$2.67M |
|
1981
Design Therapeutics
DSGN
$343M
| $3.72M | ﹤0.01% |
963,460
+4,667
| +0.5% | +$18K |
|
1982
Rhythm Pharmaceuticals
RYTM
$6.39B
| $3.71M | ﹤0.01% |
70,068
+29,649
| +73% | +$1.57M |
|
|
LINE
1983
Lineage, Inc. Common Stock
LINE
$9.56B
| $3.71M | ﹤0.01% |
63,285
+62,472
| +7,684% | +$3.66M |
|
1984
iShares US Tech Independence Focused ETF
IETC
$834M
| $3.71M | ﹤0.01% |
49,503
+13,887
| +39% | +$1.04M |
|
1985
Nuvation Bio
NUVB
$1.07B
| $3.71M | ﹤0.01% |
2,105,846
-72,116
| -3% | -$127K |
|
1986
AvePoint
AVPT
$3.31B
| $3.7M | ﹤0.01% |
256,572
-44,389
| -15% | -$641K |
|
1987
Bentley Systems
BSY
$16.1B
| $3.7M | ﹤0.01% |
94,121
+86,604
| +1,152% | +$3.41M |
|
1988
Heritage Insurance Holdings
HRTG
$763M
| $3.69M | ﹤0.01% |
256,209
+55,275
| +28% | +$797K |
|
1989
Aspen Aerogels
ASPN
$543M
| $3.69M | ﹤0.01% |
577,760
-46,470
| -7% | -$297K |
|
1990
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$13.9B
| $3.69M | ﹤0.01% |
+40,743
| New | +$3.69M |
|
1991
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$281M
| $3.69M | ﹤0.01% |
109,533
+77,533
| +242% | +$2.61M |
|
1992
Visteon
VC
$3.4B
| $3.68M | ﹤0.01% |
47,354
-136,287
| -74% | -$10.6M |
|
|
MMKT
1993
Texas Capital Government Money Market ETF
MMKT
$57.6M
| $3.67M | ﹤0.01% |
36,611
+26,581
| +265% | +$2.66M |
|
1994
SPDR S&P Semiconductor ETF
XSD
$1.48B
| $3.67M | ﹤0.01% |
18,257
-6,018
| -25% | -$1.21M |
|
|
GMOI
1995
GMO International Value ETF
GMOI
$182M
| $3.66M | ﹤0.01% |
137,290
+99,374
| +262% | +$2.65M |
|
1996
FIGS
FIGS
$1.16B
| $3.66M | ﹤0.01% |
796,658
+108,610
| +16% | +$499K |
|
|
METU
1997
Direxion Daily META Bull 2X Shares
METU
$139M
| $3.65M | ﹤0.01% |
120,177
+103,308
| +612% | +$3.14M |
|
1998
Kadant
KAI
$3.69B
| $3.65M | ﹤0.01% |
10,847
-8,821
| -45% | -$2.97M |
|
1999
Invesco FTSE RAFI Developed Markets ex-US Small-Mid ETF
PDN
$367M
| $3.65M | ﹤0.01% |
+108,947
| New | +$3.65M |
|
2000
Vaxcyte
PCVX
$4.18B
| $3.64M | ﹤0.01% |
96,387
-45,394
| -32% | -$1.71M |
|